Jenburkt Pharmaceuticals has informed that a meeting of board of directors of the company will be held on May 30, 2013, to take on record the audited financial results for the quarter and financial year ended on March 31, 2013, to recommend Dividend, if any and to declare book closure for the ensuing Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.